Herein, the decrease of these CD163+ TAMs noticed within melanomas could be involved to limit the endothelial cell recruitment through decreased growth factors excretion, and finally explain the increase in tumor necrosis as observed under Phenacetinum 4CH treatment. The gene discussed is CD163; the disease is melanoma.